Chordoma Foundation

Chordoma is a slow growing, relentless bone cancer that occurs in the head and spine in people of all ages. It is typically resistant to chemotherapy and radiation, and is prone to multiple recurrences. The average survival after diagnosis is 7 years; a statistic that the Chordoma Foundation is determined to change.

The mission of the Chordoma Foundation is to improve the lives of chordoma patients by rapidly developing effective treatments and ultimately a cure for this devastating disease. We lead a coordinated international research effort to accelerate a cure, while improving the diagnosis, treatment, and quality of life for people affected by chordoma. We serve as a bridge between patients, doctors, researchers, drug companies, government and funding agencies, representing the interests of those with chordoma, and instilling a sense of urgency in the treatment development process.

www.ChordomaFoundation.org